Suppr超能文献

[钙拮抗剂与麻醉引发的问题:药理学、相互作用、适应证]

[Problems posed by calcium antagonists and anesthesia: pharmacology, interactions, indications].

作者信息

Lehot J J, Durand P G, Arvieux C C, Boulieu R

机构信息

Hôpital Cardiovasculaire et Pneumologique L. Pradel, BP Lyon-Montchat.

出版信息

Ann Cardiol Angeiol (Paris). 1993 Oct;42(8):431-7.

PMID:8122852
Abstract

Calcium-channel inhibitors are widely used in therapeutics. Many patients administered calcium channel inhibitors undergo surgical procedures and the cardiologists or the anaesthesiologists are concerned with pharmacological interactions with anaesthetic agents such as halogenated gases. The combination of calcium channel inhibitors and halogenated anaesthetics may exert an additive effect on myocardial depression, conduction disturbances and arterial vasodilatation. The continuation of oral calcium channel inhibitors until the day of surgery is recommended provided the use of enflurane is restrained. Calcium-channel inhibitors such as dihydropyridines are currently administered intravenously to control intra and postoperative arterial hypertension while verapamil and diltiazem are used to treat supraventricular arrhythmias and myocardial ischaemic episodes. In patients with cardiac disease, haemodynamic monitoring may allow to anticipate or to treat episodes of cardiac dysfunction associated with I.V. calcium-channel inhibitors during the perioperative period.

摘要

钙通道抑制剂在治疗中被广泛应用。许多接受钙通道抑制剂治疗的患者需要接受外科手术,心脏病专家或麻醉师会关注其与卤化气体等麻醉剂的药物相互作用。钙通道抑制剂与卤化麻醉剂联合使用可能会对心肌抑制、传导障碍和动脉血管舒张产生相加作用。如果限制使用恩氟烷,建议在手术当天继续口服钙通道抑制剂。目前,二氢吡啶类等钙通道抑制剂通过静脉给药以控制术中和术后的动脉高血压,而维拉帕米和地尔硫䓬则用于治疗室上性心律失常和心肌缺血发作。对于患有心脏病的患者,血流动力学监测可能有助于预测或治疗围手术期与静脉注射钙通道抑制剂相关的心脏功能障碍发作。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验